Remyelination therapy goes to trial for multiple sclerosis

Pedro Brugarolas; Brian Popko

doi:10.1212/NXI.0000000000000026

Remyelination therapy goes to trial for multiple sclerosis

Pedro Brugarolas, Brian Popko^*

^*Corresponding author for this work

Neurology

Research output: Contribution to journal › Editorial › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	e26
Journal	Neurology: Neuroimmunology and NeuroInflammation
Volume	1
Issue number	2
DOIs	https://doi.org/10.1212/NXI.0000000000000026
State	Published - Aug 2014

ASJC Scopus subject areas

Clinical Neurology
Neurology

Access to Document

10.1212/NXI.0000000000000026

Cite this

@article{eceee9ae89f94c34ae5454ff2c0a3c7f,

title = "Remyelination therapy goes to trial for multiple sclerosis",

author = "Pedro Brugarolas and Brian Popko",

year = "2014",

month = aug,

doi = "10.1212/NXI.0000000000000026",

language = "English (US)",

volume = "1",

pages = "e26",

journal = "Neurology: Neuroimmunology and NeuroInflammation",

issn = "2332-7812",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "2",

}

TY - JOUR

T1 - Remyelination therapy goes to trial for multiple sclerosis

AU - Brugarolas, Pedro

AU - Popko, Brian

PY - 2014/8

Y1 - 2014/8

UR - http://www.scopus.com/inward/record.url?scp=84926183734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926183734&partnerID=8YFLogxK

U2 - 10.1212/NXI.0000000000000026

DO - 10.1212/NXI.0000000000000026

M3 - Editorial

C2 - 25340076

AN - SCOPUS:84926183734

SN - 2332-7812

VL - 1

SP - e26

JO - Neurology: Neuroimmunology and NeuroInflammation

JF - Neurology: Neuroimmunology and NeuroInflammation

IS - 2

ER -

Remyelination therapy goes to trial for multiple sclerosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this